|
US5912268A
(en)
*
|
1995-05-22 |
1999-06-15 |
Alza Corporation |
Dosage form and method for treating incontinence
|
|
US6262115B1
(en)
*
|
1995-05-22 |
2001-07-17 |
Alza Coporation |
Method for the management of incontinence
|
|
IL142778A0
(en)
*
|
1998-12-02 |
2002-03-10 |
Darwin Discovery Ltd |
Therapeutic product and its use
|
|
WO2000043003A1
(en)
*
|
1999-01-21 |
2000-07-27 |
Darwin Discovery Limited |
The therapeutic use of r-warfarin as anticoagulant
|
|
US20030170181A1
(en)
*
|
1999-04-06 |
2003-09-11 |
Midha Kamal K. |
Method for preventing abuse of methylphenidate
|
|
PE20010623A1
(es)
*
|
1999-10-05 |
2001-07-07 |
Gruenenthal Chemie |
Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria
|
|
WO2001034125A2
(en)
*
|
1999-11-09 |
2001-05-17 |
Darwin Discovery Limited |
Therapeutic use and formulation of (-)-tramadol
|
|
DE10004926A1
(de)
|
2000-02-04 |
2001-08-09 |
Gruenenthal Gmbh |
Verfahren zur enzymatischen Racematspaltung von Aminomethyl-Aryl-Cyclohexanol-Derivaten
|
|
WO2001064202A2
(en)
|
2000-03-01 |
2001-09-07 |
Euro-Celtique S.A. |
Tramadol for the treatment of functional gastrointestinal disorders
|
|
US20010036959A1
(en)
*
|
2000-04-03 |
2001-11-01 |
Gabel Rolf Dieter |
Carvedilol-hydrophilic solutions
|
|
EP1322303A1
(en)
*
|
2000-10-03 |
2003-07-02 |
Penwest Pharmaceuticals Co. |
Delivery system for multi-pharmaceutical active materials at various release rates
|
|
CA2426811A1
(en)
*
|
2000-10-24 |
2002-08-29 |
Smithkline Beecham Corporation |
Novel formulations of carvedilol
|
|
US6562871B1
(en)
*
|
2000-11-06 |
2003-05-13 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Dry granulation of pharmaceutical formulation comprising mexiletine
|
|
DE10108122A1
(de)
|
2001-02-21 |
2002-10-02 |
Gruenenthal Gmbh |
Arzneimittel auf Basis von Tramadol
|
|
IN191028B
(enExample)
*
|
2001-05-17 |
2003-09-13 |
Sun Pharmaceutical Ind Ltd |
|
|
US8101209B2
(en)
*
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
|
US6780891B2
(en)
|
2001-11-30 |
2004-08-24 |
Sepracor Inc. |
Tramadol analogs and uses thereof
|
|
US20050182056A9
(en)
*
|
2002-02-21 |
2005-08-18 |
Seth Pawan |
Modified release formulations of at least one form of tramadol
|
|
US8128957B1
(en)
|
2002-02-21 |
2012-03-06 |
Valeant International (Barbados) Srl |
Modified release compositions of at least one form of tramadol
|
|
US20040151772A1
(en)
*
|
2002-11-08 |
2004-08-05 |
Egalet A/S |
Controlled release carvedilol compositions
|
|
AU2003288608A1
(en)
*
|
2002-12-20 |
2004-07-14 |
Ranbaxy Laboratories Limited |
Controlled release, multiple unit drug delivery systems
|
|
US20040220277A1
(en)
*
|
2003-02-10 |
2004-11-04 |
Couch Richard A. |
Enantiomeric amphetamine compositions
|
|
WO2004103361A2
(en)
*
|
2003-05-20 |
2004-12-02 |
Ranbaxy Laboratories Limited |
A pharmaceutical dosage form of citalopram
|
|
WO2004110411A2
(fr)
*
|
2003-06-06 |
2004-12-23 |
Ethypharm |
Comprime orodispersible multicouche
|
|
US20060172006A1
(en)
*
|
2003-10-10 |
2006-08-03 |
Vincent Lenaerts |
Sustained-release tramadol formulations with 24-hour clinical efficacy
|
|
US20050143350A1
(en)
*
|
2003-11-19 |
2005-06-30 |
Seed John C. |
Combination drug therapy to treat obesity
|
|
WO2005051322A2
(en)
*
|
2003-11-25 |
2005-06-09 |
Sb Pharmco Puerto Rico Inc. |
Controlled release pharmaceutical formulations comprising carvedilol, free based and its salts
|
|
US20050169994A1
(en)
*
|
2003-11-25 |
2005-08-04 |
Burke Matthew D. |
Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
|
|
CA2580329C
(en)
|
2004-09-13 |
2015-01-06 |
Chrono Therapeutics Inc. |
Biosynchronous transdermal drug delivery
|
|
CA2581282A1
(en)
*
|
2004-10-01 |
2006-04-13 |
Nippon Zoki Pharmaceutical Co., Ltd. |
Solid pharmaceutical preparation
|
|
US8795723B2
(en)
|
2005-09-09 |
2014-08-05 |
Angelini Pharma Inc. |
Sustained drug release compositions
|
|
EP1976488A4
(en)
*
|
2006-01-12 |
2010-02-10 |
Wockhardt Ltd |
ALFUZOSIN PROLONGED RELEASE PREPARATIONS
|
|
ES2744495T3
(es)
*
|
2006-03-30 |
2020-02-25 |
Nippon Zoki Pharmaceutical Co |
Preparación farmacéutica sólida
|
|
KR20130122023A
(ko)
|
2007-02-12 |
2013-11-06 |
디엠아이 바이오사이언시스 인코포레이티드 |
트라마돌의 부작용을 감소시키는 방법
|
|
CA2677690C
(en)
*
|
2007-02-12 |
2012-05-15 |
James V. Winkler |
Treatment of comorbid premature ejaculation and erectile dysfunction
|
|
EP1977746B8
(en)
|
2007-04-02 |
2014-09-24 |
Parkinson's Institute |
Methods and compositions for reduction of side effects of therapeutic treatments
|
|
CA2974324A1
(en)
|
2015-01-28 |
2016-08-04 |
Zita S. Netzel |
Drug delivery methods and systems
|
|
EP3565617A1
(en)
|
2017-01-06 |
2019-11-13 |
Chrono Therapeutics Inc. |
Transdermal drug delivery devices and methods
|
|
US11596779B2
(en)
|
2018-05-29 |
2023-03-07 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
|
CA3119992A1
(en)
|
2018-11-16 |
2020-05-22 |
Morningside Venture Investments Limited |
Thermally regulated transdermal drug delivery system
|